Medical Oncologist With Interest In Breast Cancer Treatment

Medical Oncologist with interest in Breast Cancer Treatment Localização: Centro ChampalimaudEntidade Empregadora: Fundação ChampalimaudRegime: Tempo InteiroPosição: Medico/aInício da Candidatura: 30 Ago. 2024 About the Position We are seeking a dedicated and experienced Medical Oncologist with interest in breast cancer treatment to join our dynamic and multidisciplinary oncology team. This is a full-time position, primarily focused on outpatient clinical care, with responsibilities that include on-call duties and collaboration with inpatient services. We offer a competitive salary. Key Responsibilities Provide high-quality care to breast cancer patients in the outpatient clinical setting; Participate in on-call rotations, approximately 12 hours twice monthly, to support chemotherapy services; Offer consultancy for the inpatient oncology floor as needed; Collaborate with a multidisciplinary team to assess patient needs accurately and develop personalised treatment plans; Participate actively inweekly clinical and educational meetings; Engage in clinical trials, including the review of clinical research protocols, patient recruitment, and treatment within both industry-sponsored and academic trials; Potential for protectedresearch time for candidates who meet specific selection criteria. Desired Qualifications & Experience MD with specialised training in Medical Oncology and eligibility to practice in the EU/Portugal (equivalent to "Assistente Hospitalar" or "Consultant"). Proven experience in the medical treatment of breast cancer patients. Experience and active involvement in clinical trials. Proficiency in spoken and written Portuguese and English. Strong motivation to work in a fast-paced, clinical environment. Excellent interpersonal and communication skills. Application Process Interested candidates are invited to submit their CV along with a cover letter detailing their relevant experience and motivation for applying to Deadline for Applications: 31 December 2024. #J-18808-Ljbffr